-
Signature
-
/s/ Andrea F. Wainer by Jessica H. Paik, Attorney-in-Fact
-
Issuer symbol
-
ABT
-
Transactions as of
-
29 Jan 2024
-
Net transactions value
-
-$2,622,300
-
Form type
-
4
-
Filing time
-
31 Jan 2024, 17:30:57 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ABT |
Common shares without par value |
Options Exercise |
$1,110,000 |
+25,000 |
+38% |
$44.40 |
90,027 |
29 Jan 2024 |
Direct |
|
| transaction |
ABT |
Common shares without par value |
Sale |
$2,812,500 |
-25,000 |
-28% |
$112.50 |
65,027 |
29 Jan 2024 |
Direct |
|
| transaction |
ABT |
Common shares without par value |
Options Exercise |
$1,048,950 |
+17,500 |
+27% |
$59.94 |
82,527 |
29 Jan 2024 |
Direct |
|
| transaction |
ABT |
Common shares without par value |
Sale |
$1,968,750 |
-17,500 |
-21% |
$112.50 |
65,027 |
29 Jan 2024 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ABT |
Option (right to buy) |
Options Exercise |
$0 |
-25,000 |
-65% |
$0.000000 |
13,271 |
29 Jan 2024 |
Common Shares |
25,000 |
$44.40 |
Direct |
F1 |
| transaction |
ABT |
Option (right to buy) |
Options Exercise |
$0 |
-17,500 |
-27% |
$0.000000 |
46,949 |
29 Jan 2024 |
Common Shares |
17,500 |
$59.94 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: